Interpace Biosciences, Inc.
IDXG
$0.95
$0.077.35%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 4.81M | 5.58M | 8.65M | 7.71M | 6.86M |
| Total Depreciation and Amortization | 811.00K | 789.00K | 778.00K | 748.00K | 723.00K |
| Total Amortization of Deferred Charges | 42.00K | 26.00K | 11.00K | -- | 0.00 |
| Total Other Non-Cash Items | 565.00K | 947.00K | 740.00K | 872.00K | 1.06M |
| Change in Net Operating Assets | -1.35M | -2.28M | -4.24M | -4.69M | -4.04M |
| Cash from Operations | 4.88M | 5.06M | 5.94M | 4.65M | 4.60M |
| Capital Expenditure | -447.00K | -852.00K | -848.00K | -876.00K | -889.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Investing | -447.00K | -852.00K | -848.00K | -876.00K | -889.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -4.90M | -5.50M | -6.50M | -5.60M | -4.10M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -46.00K | -46.00K | -46.00K | -46.00K | -32.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -174.00K | -174.00K | -161.00K | -161.00K | -2.50M |
| Cash from Financing | -5.12M | -5.72M | -6.71M | -5.81M | -6.63M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -690.00K | -1.52M | -1.62M | -2.04M | -2.92M |